Quarterly Consolidated Statement Of Cash Flows

COSMOS Pharmaceutical Corporation - Filing #7542519

Concept 2023-06-01 to
2023-08-31
2022-06-01 to
2022-08-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
9,636,000,000 JPY
9,581,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.